Warberg Asset Management LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTXW and the CUSIP is 10778Y112. A total of 9 filers reported holding BRIACELL THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Warberg Asset Management LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q1 2022$166,000
+27.7%
32,092
+18.9%
0.00%
-95.2%
Q3 2021$130,000
+124.1%
27,000
-15.6%
0.02%
+90.9%
Q2 2021$58,000
-9.4%
32,000
-46.1%
0.01%
-47.6%
Q1 2021$64,00059,4000.02%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Murchinson Ltd. 469,950$2,444,0000.47%
K.J. Harrison & Partners Inc 160,057$832,0000.13%
Redmond Asset Management, LLC 75,000$390,0000.12%
ARMISTICE CAPITAL, LLC 375,000$1,950,0000.04%
ZEKE CAPITAL ADVISORS, LLC 45,000$234,0000.01%
Warberg Asset Management LLC 32,092$166,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 16,092$84,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 1,137$6,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders